Anthony Baldor - 28 Jul 2026 Form 4 Insider Report for Vivani Medical, Inc. (VANI)

Reporting relationship: Chief Financial Officer
Issuer ticker: VANI
Reported as of: 28 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Jul 2026, 20:26:34 UTC
Prior SEC filing: 17 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Adam Mendelsohn, Attorney-in-fact

Key filing fact

Anthony Baldor filed Form 4 for Vivani Medical, Inc. (VANI) on 30 Jul 2026.

Key facts

This page summarizes Anthony Baldor's Form 4 filing for Vivani Medical, Inc. (VANI).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 30 Jul 2026, 20:26.

Change

Previous filing in this sequence was filed on 17 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002073424 Primary reporting owner

Baldor Anthony

Relationship: Chief Financial Officer
Address: C/O VIVANI MEDICAL, INC., 1350 S. LOOP ROAD, ALAMEDA
Signature: /s/ Adam Mendelsohn, Attorney-in-fact
Signature date: 30 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VANI transaction Derivative

Common Stock Option

Award

Transaction value
Shares: +75,000
Change %
Price: $0.000000^*
Shares after: 75,000
Date: 28 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 75,000
Exercise price: $1.31
Footnotes: F1

VANI transaction Derivative

RSUs

Award

Transaction value
Shares: +37,500
Change %
Price: $0.000000^*
Shares after: 37,500
Date: 28 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,500
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

Footnote F2

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

Footnote F3

The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

SEC remarks

Exhibit 24 - Power of Attorney.